Advanced Search

Technical Analysis for LEGN - Legend Biotech Corporation

Grade Last Price % Change Price Change
grade D 38.32 -1.44% -0.56
LEGN closed down 1.44 percent on Friday, July 10, 2020, on 25 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
3 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical LEGN trend table...
Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
NR7 Range Contraction 0.00%
Fell Below 20 DMA Bearish -1.44%
Multiple of Ten Bearish Other -1.44%
Crossed Above 20 DMA Bullish -3.09%
Hot IPO Pullback Bullish Swing Setup 3.12%
Fell Below 20 DMA Bearish -2.15%
Hot IPO Pullback Bullish Swing Setup -2.15%
Multiple of Ten Bearish Other -2.15%
Hot IPO Pullback Bullish Swing Setup -3.26%
Older EOD signals for LEGN ...
View Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators Basic chart:

Profile

Legend Biotech Corporation develops cell therapy solutions for cancer patients. The company was founded in 2014 and is based in Cayman Islands. The company operates as a subsidiary of Genscript Biotech Corporation.
Cancer Life Sciences Cell Therapy Tax Spotlight Innovation

Is LEGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jul 8 J.P. Morgan Says These 3 Stocks Will Surge Over 30% From Current Levels
Jul 2 The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts
Jul 1 The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes
Jun 28 The Week Ahead In Biotech (June 28- July 4): Pending Clinical Readouts In Focus During A Short Holiday Week
Jun 24 The Daily Biotech Pulse: MediciNova On Track For European Patent Win, Partial Clinical Hold Lifted For Innate Pharma, Tela Bio Details Coronavirus Impact
Jun 23 The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
Jun 16 Nasdaq President Nelson Griggs on the 2020 IPO market
Jun 9 Legend Biotech Announces Three New Appointments to the Board of Directors
Jun 9 Legend Biotech Corporation Announces Closing of Initial Public Offering
Jun 5 Legend Biotech's IPO Blows Past Expectations
See more LEGN news...

Indicators

Indicator Value
52 Week High 43.2399
52 Week Low 35.0
Average Volume 363,730
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 39.51
10-Day Moving Average 39.56
Average True Range 2.30
ADX 0.0
+DI 20.18
-DI 19.49
Chandelier Exit (Long, 3 ATRs ) 36.35
Chandelier Exit (Short, 3 ATRs ) 42.45
Upper Bollinger Band 42.16
Lower Bollinger Band 36.86
Percent B (%b) 0.28
BandWidth 13.40
MACD Line 0.16
MACD Signal Line 0.43
MACD Histogram -0.267
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 40.72
Resistance 3 (R3) 40.88 40.24 40.32
Resistance 2 (R2) 40.24 39.63 40.16 40.19
Resistance 1 (R1) 39.28 39.25 38.96 39.12 40.05
Pivot Point 38.64 38.64 38.48 38.56 38.64
Support 1 (S1) 37.68 38.03 37.36 37.52 36.59
Support 2 (S2) 37.04 37.65 36.96 36.45
Support 3 (S3) 36.08 37.04 36.32
Support 4 (S4) 35.92